

Targeted DNA/RNA Sequencing Market Scope:
Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The Targeted DNA/RNA Sequencing market research reports indicate a growing market size due to advancements in technology and increased demand for personalized medicine. The market is expected to reach a value of $8.5 billion by 2025, driven by the rising prevalence of cancer and genetic disorders. Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ Illumina, Inc.
◍ F. Hoffmann-La Roche Ltd
◍ Agilent Technologies
◍ GATC Biotech Ag
◍ Oxford Nanopore Technologies
◍ Thermo Fisher Scientific, Inc.
◍ DNASTAR Inc.
◍ QIAGEN
◍ BGI
◍ Perkin Elmer, Inc.
◍ Pacific Biosciences of California, Inc.
◍ Bio-Rad Laboratories, Inc.
◍ Integrated DNA Technologies, Inc.
◍ RainDance Technologies, Inc.
◍ PierianDx
◍ Genomatix GmbH
◍ Macrogen, Inc.
The Targeted DNA/RNA Sequencing Market is highly competitive with key players such as Illumina, Roche, Agilent, and Thermo Fisher. These companies offer innovative sequencing technologies that provide accurate and efficient analysis of genetic material, driving market growth. Sales revenue: Illumina - $3.54B, Roche - $29.5B, Agilent - $4.91B.
◍ Human Biomedical Research
◍ Plant & Animal Sciences
◍ Drug Discovery
◍ Others
◍ DNA-based Targeted Sequencing
◍ RNA-based Targeted Sequencing
Request Sample Report